Search research articles
Contact Us
Filters
Showing results (151-160 of 218) with videos related to
Page
of 22
Sort By:
Chemotherapy
|
August 22, 2012
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer
Simon J Crabb, Jennifer Bradbury, Luke Nolan, et al.
Journal of the National Cancer Institute
|
September 19, 2002
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis
Urszula Bugajska, Nikolaos T Georgopoulos, Jennifer Southgate, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 27, 2014
Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization
Jane E Willoughby, Jonathan P Kerr, Anne Rogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2009
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)
W S Owadally, M R Sydes, J A Radford, et al.
Oncogene
|
September 20, 2006
Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes
F Habens, A S Lapham, C L Dallman, et al.
Insect Biochemistry and Molecular Biology
|
May 23, 2007
Ligand binding by recombinant domains from insect ecdysone receptors
L D Graham, W M Johnson, A Pawlak-Skrzecz, et al.
Cancer Immunology, Immunotherapy : CII
|
April 2, 2013
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs
Ann L White, H T Claude Chan, Ruth R French, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2018
Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
Ronald Boellaard, Carsten Kobe, Josée M Zijlstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
Luca Ceriani, Lisa Milan, Maria Cristina Pirosa, et al.
Cancer Immunology, Immunotherapy : CII
|
April 23, 2013
Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells
Ben C King, Angela D Hamblin, Philip M Savage, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 218) with videos related to
Sort By:
Page
of 22
Chemotherapy
|
August 22, 2012
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer
Simon J Crabb, Jennifer Bradbury, Luke Nolan, et al.
Journal of the National Cancer Institute
|
September 19, 2002
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis
Urszula Bugajska, Nikolaos T Georgopoulos, Jennifer Southgate, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 27, 2014
Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization
Jane E Willoughby, Jonathan P Kerr, Anne Rogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2009
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)
W S Owadally, M R Sydes, J A Radford, et al.
Oncogene
|
September 20, 2006
Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes
F Habens, A S Lapham, C L Dallman, et al.
Insect Biochemistry and Molecular Biology
|
May 23, 2007
Ligand binding by recombinant domains from insect ecdysone receptors
L D Graham, W M Johnson, A Pawlak-Skrzecz, et al.
Cancer Immunology, Immunotherapy : CII
|
April 2, 2013
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs
Ann L White, H T Claude Chan, Ruth R French, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2018
Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
Ronald Boellaard, Carsten Kobe, Josée M Zijlstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
Luca Ceriani, Lisa Milan, Maria Cristina Pirosa, et al.
Cancer Immunology, Immunotherapy : CII
|
April 23, 2013
Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells
Ben C King, Angela D Hamblin, Philip M Savage, et al.
Page
of 22